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Center For Acute Disease Epidemiology 
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Items for this week’s EPI Update include:  
•       Influenza Update: Influenza Links & Antiviral Medications  
•       IDPH Recommendations Regarding Stockpiling Antiviral 
Medications  
•       Pertussis Vaccine Study  
•       Rx for Survival  
•       Polio in Minnesota  
•       Occupational Exposure to HIV - Updated Guidelines  
•       Announcements / Upcoming Meetings  
Avian Influenza Update/Pandemic Influenza Preparedness  
International  
The H5N1 strain identified in Asia has been recently identified in Turkey and Romania.  
In all three countries the strain was identified in poultry.  No human cases have been 
reported in these counties to date. Though the reported mortality rate is high, it is 
important to note that there are likely mild cases of H5N1 infection not captured by local, 
national and WHO surveillance efforts.   
October 15th -Europe-the Standing Committee on Food Chain and Animal Health meet 
and are expected to review proposals on prevention measures.  This includes asking each 
member state to define which areas are at risk and apply necessary measures to reduce 
risk to separate wild birds from poultry. 
October 14th- Eurasia-Russian authorities ask World Organization for Animal Health to 
send a team to Siberia.  
October 20th - World Health Organization- there have been 118 confirmed cases in 
Indonesia, Thailand, Vietnam and Cambodia.  Of those 118 cases, 61 have died.  The 
most recent fatality occurred in Thailand.   
U.S.  
Federal public health officials are working to finalize a national pandemic influenza 
response plan and to provide guidance to state health departments for the development of 
state plans.  In addition new and updated resources are being posted at the CDC web site 
on avian influenza. 
Iowa  
Updated fact sheets on pandemic and avian influenza, as well as antiviral medications are 
now available on the IDPH website.  The fact sheets contain updated information for 
health care providers and general public audiences.  The fact sheets are available on our 
website at: <http://www.idph.state.ia.us/adper/flu.asp>.   
   
IDPH Recommendations Regarding Stockpiling Antiviral Medications  
The Iowa Department of Public health has issued a Public Health Bulletin titled: 
“Recommendations for Health Care Providers Regarding Stockpiling Influenza Antiviral 
Medication” and is encouraging all health care providers to review.  The 
recommendations are available on our website at:  
<http://www.idph.state.ia.us/adper/flu.asp>.   
 
Pertussis Vaccine Study  
National Institute of Health (NIH) has issued a news release with the headlines 
“ACELLULAR PERTUSSIS VACCINE PROVES EFFECTIVE IN ADULTS, 
ADOLESCENTS.” The news release is referencing a study published in the New 
England Journal of Medicine.  The title of the article is “A vaccine to protect adults and 
adolescents against illness due to ‘Bordetella pertussis’ infection -- or whooping cough -- 
has proved more than 90 percent effective in a national, large-scale clinical study.”   
While this is positive news, the Advisory Committee on Immunization Practices (ACIP) 
voted to recommend routine use of these products for adolescents; however, the 
committee has not yet recommended these vaccines for adults.  ACIP is scheduled to 
meet at the end of the month to review pertussis immunization strategies for adults.  
Despite positive results related to the new Tdap vaccines, close contacts to a case of 
pertussis need to be treated / prophylaxed with antibiotics regardless of their 
immunization status.  Instances of pertussis have begun to increase again in Iowa this 
fall.  During 2004, and to date in 2005, over 50% of confirmed pertussis cases occur in 
patients between ages 10 to 18, with the highest concentrations in patients aged 12 - 15 
(middle-school aged children).  Health Care Professionals are encouraged to follow 
recommended guidelines for vaccination, prophylaxis, and treatment for pertussis within 
IDPH’s EPI manual.  Addition resources and education products can be found at the 
following links: 
Guidelines for use of Tdap vaccines <http://www.cdc.gov/nip/vaccine/tdap/default.htm>  
October 10, 2005 Public Health Bulletin on Pertussis 
<http://www.idph.state.ia.us/adper/common/pdf/pertussis/pertussis_public_health_bulleti
n.pdf> 
Influenza vs. Cold vs. Pertussis 
<http://www.idph.state.ia.us/adper/common/pdf/flu/flu_colds_pertussis.pdf>  
Rx for Survival  
Rx for Survival highlights many of the public health accomplishments that have more 
than doubled life expectancy in developed countries within the past century.  The 
highlights cover such topics as vaccines to antibiotics, and/or environmental health to 
nutrition. 
Rx for Survival is more than just a documentary, and includes a six-part series telling 
compelling stories of public health workers across the globe.  The producers have created 
partnerships with media, schools, and public health agencies across the globe.  A 
simultaneous media effort will reach over 200 million Americans, promoting public 
health and offering viewers a way to make a difference.  For more information, follow 
this link <http://www.tchd.org/special.htm>. 
Polio in Minnesota  
On September 29, 2005, the Minnesota Department of Health (MDH) identified 
poliovirus type 1 in an unvaccinated, immunocompromised infant girl aged 7 months (the 
index patient) in an Amish community whose members predominantly were unvaccinated 
for polio. The patient has no paralysis; the source of the patient's infection is unknown. 
Subsequently, poliovirus infections in three other children within the index patient's 
community have been documented. 
Most poliovirus infections are asymptomatic or cause mild, febrile disease. Poliovirus 
infections occasionally cause aseptic meningitis and one out of 200 infections from 
poliovirus type 1 results in paralytic poliomyelitis, characterized by acute onset of flaccid 
paralysis that is typically asymmetric and associated with a prodromal fever.  Poliovirus 
is spread through fecal material, oral secretions, and fomites.  Widespread transmission 
among vaccinated health-care workers or in a community with high vaccination coverage 
is unlikely because fully vaccinated persons are not at risk for disease from this or other 
polioviruses and seldom shed the virus for longer than a week if they are infected.   
The National Immunization Survey reports that polio vaccination coverage in Minnesota 
is 93% for children aged 19--35 months and 98% for school-aged children; however, 
communities of unvaccinated persons exist in Minnesota and many other states (5).  The 
risk for transmission in communities with low vaccination coverage is high.  The 
estimated rate of transmission for wild poliovirus among unvaccinated household 
contacts is 73%--96% (6).  Contacts between persons in communities with low 
vaccination coverage pose the potential for transmission of this poliovirus to other 
communities in the United States, Canada, and other countries.   
This outbreak reminds us why it remains important to promote vaccinations.  
Occupational Exposure to HIV - Updated Guidelines  
CDC has released updated guidelines for the management of occupational exposures to 
HIV.  Most importantly, the guidelines modify and expand the list of antiretroviral 
medications that can be considered for post-exposure prophylaxis (PEP).  The previous 
first-choice regimen was found to have unacceptably high levels of toxicity and side 
effects.  Newer regimens with lower toxicity are now recommended.  Other factors, such 
as information on antiretroviral resistance in the source patient or current medications in 
the exposed person should also be considered when formulating the PEP regimen.  
If indicated, PEP should be initiated as soon as possible, preferably within hours.  
Consultation with persons having expertise in antiretroviral therapy and HIV 
transmission is desirable and can be achieved by calling the PEPline at 1-888-448-4911, 
7 days a week.  Reevaluation of exposed persons is strongly encouraged within 72 hours 
post exposure, especially if more information about the exposure or source becomes 
available.  The report is available at <http://www.cdc.gov/mmwr/pdf/rr/rr5409.pdf> 
 
Meeting Announcements and Training Opportunities  
•       The next Fall Epidemiology Updates are taking place on Tuesday 
October 25, 2005, in Marshalltown and Thursday, October 27, 2005, in Marion.  
See the Fall Epidemiology Updates Brochure, now available online at the Iowa 
Department of Public Health’s web site, for more details. 
<http://www.idph.state.ia.us/common/pdf/conferences/disease_prevention
_fall.pdf>  
•       SAVE THE DATE: "When Antibiotics Don't Work"  
IARTF Grand Rounds Teleconference scheduled for December 14, 2005, 
from Noon to 1:00 PM.  Topics include:  
1)      Antibiotic Resistance Surveillance  
2)      Decreasing Antibiotic Resistance Through Patient Education  
3)      Community Acquired MRSA  
•       Upper Midwest Center for Public Health Preparedness Grand 
Rounds Series: The Role of Blood Centers in Emergency Response will be 
held on Thursday, October 27, 2005.  For more information, see the Grand 
Rounds web site at <http://www.public-
health.uiowa.edu/icphp/grand_rounds/current_session/gr102705.html> 
•       October is Children’s Health Month  
Children’s Health Month is celebrated in October, but children’s health is 
important year-round.  Visit <http://www.childrenshealth.gov/> to view 
information on topics such as childhood illnesses, education, and child 
care, health promotion, limiting environmental hazards, reducing risky 
behaviors, and safety issues.  The calendar is a point of interest. 
 
